LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIALS NETWORK
$1,070,580,281
AI Summary
This $1.1 billion award from HHS funds the Fred Hutchinson Cancer Center in Washington State to lead a global HIV vaccine clinical trials network. The long-running program coordinates international research efforts to develop an effective HIV vaccine, one of the most important challenges in global public health.
Key Points
- 01Funded at approximately $1.1 billion for HIV vaccine research
- 02Supports a global clinical trials network for HIV vaccine development
- 03Awarded to the Fred Hutchinson Cancer Center in Seattle, Washington
- 04Active since June 2006, running through November 2027
- 05One of the largest and longest-running HIV vaccine research programs
Award Details
Official Source
View on USAspending.govAd Space (inline)
Related Awards
Department of DefenseAug 1, 2016
OtherHealthcare
IGF::OT::IGF
$51.2B
HUMANA GOVERNMENT BUSINESS INC
Department of DefenseAug 1, 2016
OtherHealthcare
IGF::OT::IGF MANAGED CARE SUPPORT SERVICES IN SUPPORT OF THE TRICARE PROGRAM
$23.5B
HEALTH NET FEDERAL SERVICES, LLC
Department of DefenseFeb 1, 2023
OtherHealthcare
TRICARE MANAGED CARE SUPPORT SERVICES CONTRACT, 5TH GENERATION EAST REGION
$5.3B
HUMANA GOVERNMENT BUSINESS INC
Department of DefenseJan 1, 2024
OtherHealthcare
TRICARE MANAGED CARE SUPPORT SERVICES CONTRACT, 5TH GENERATION WEST REGION
$4.4B
TRIWEST HEALTHCARE ALLIANCE CORP
Quick Summary
- Amount
- $1.1B
- Agency
- Department of Health and Human Services
- Recipient
- FRED HUTCHINSON CANCER CENTER
- Type
- Other
From the Civic Digest Network
Ad Space (rectangle)